Cargando…

Long-term organoid culture of a small intestinal neuroendocrine tumor

Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are rare and highly heterogeneous neoplasms whose incidence has markedly increased over the last decades. A grading system based on the tumor cells’ proliferation index predicts high-risk for G3 NETs. However, low-to-intermediate grade (G1/G2)...

Descripción completa

Detalles Bibliográficos
Autores principales:	D’Agosto, Sabrina, Fiorini, Elena, Pezzini, Francesco, Delfino, Pietro, Simbolo, Michele, Vicentini, Caterina, Andreani, Silvia, Capelli, Paola, Rusev, Borislav, Lawlor, Rita T., Bassi, Claudio, Landoni, Luca, Pea, Antonio, Luchini, Claudio, Scarpa, Aldo, Corbo, Vincenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10112019/ https://www.ncbi.nlm.nih.gov/pubmed/37082125 http://dx.doi.org/10.3389/fendo.2023.999792

Ejemplares similares

Combinatorial Effect of Magnetic Field and Radiotherapy in PDAC Organoids: A Pilot Study
por: Nicosia, Luca, et al.
Publicado: (2020)

Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine
por: Simbolo, Michele, et al.
Publicado: (2018)

Loss of FGFR4 promotes the malignant phenotype of PDAC
por: D’Agosto, Sabrina, et al.
Publicado: (2022)

Preclinical Modelling of PDA: Is Organoid the New Black?
por: D’Agosto, Sabrina, et al.
Publicado: (2019)

Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
por: Luchini, Claudio, et al.
Publicado: (2021)

Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma
por: Simbolo, Michele, et al.
Publicado: (2018)

Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
por: Filippini, Dea, et al.
Publicado: (2019)

An Insight on Functioning Pancreatic Neuroendocrine Neoplasms
por: Bevere, Michele, et al.
Publicado: (2023)

Generation of Pancreatic Organoid-Derived Isografts
por: D’Agosto, Sabrina, et al.
Publicado: (2020)

Exosomal miRNA signatures of pancreatic lesions
por: Vicentini, Caterina, et al.
Publicado: (2020)

BRCA somatic and germline mutation detection in paraffin embedded ovarian cancers by next-generation sequencing
por: Mafficini, Andrea, et al.
Publicado: (2016)

Artificial intelligence in oncology: current applications and future perspectives
por: Luchini, Claudio, et al.
Publicado: (2021)

Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors
por: Paiella, Salvatore, et al.
Publicado: (2017)

Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin‐remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D
por: Simbolo, Michele, et al.
Publicado: (2016)

Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas
por: Amato, Eliana, et al.
Publicado: (2018)

Reporting Tumor Molecular Heterogeneity in Histopathological Diagnosis
por: Mafficini, Andrea, et al.
Publicado: (2014)

CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms
por: D’Onofrio, Mirko, et al.
Publicado: (2019)

CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype
por: Mattiolo, Paola, et al.
Publicado: (2020)

Undifferentiated Sarcomatoid Carcinoma of the Pancreas: From Histology and Molecular Pathology to Precision Oncology
por: Gkountakos, Anastasios, et al.
Publicado: (2022)

Ampulla of Vater carcinoma: Molecular landscape and clinical implications
por: Pea, Antonio, et al.
Publicado: (2018)

Histo-molecular oncogenesis of pancreatic cancer: From precancerous lesions to invasive ductal adenocarcinoma
por: Riva, Giulio, et al.
Publicado: (2018)

Clinical Application of MicroRNA Testing in Neuroendocrine Tumors of the Gastrointestinal Tract
por: Vicentini, Caterina, et al.
Publicado: (2014)

CD200 expression is a feature of solid pseudopapillary neoplasms of the pancreas
por: Lawlor, Rita T., et al.
Publicado: (2018)

Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
por: Simbolo, Michele, et al.
Publicado: (2014)

Organoid-Transplant Model Systems to Study the Effects of Obesity on the Pancreatic Carcinogenesis in vivo
por: Lupo, Francesca, et al.
Publicado: (2020)

Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and (18)F-FDG Uptake
por: Beleù, Alessandro, et al.
Publicado: (2020)

Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
por: Young, Kate, et al.
Publicado: (2021)

Neuroendocrine neoplasms of the biliary tree, liver and pancreas: a pathological approach
por: Luchini, Claudio, et al.
Publicado: (2021)

DNA Qualification Workflow for Next Generation Sequencing of Histopathological Samples
por: Simbolo, Michele, et al.
Publicado: (2013)

RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes
por: Amato, Eliana, et al.
Publicado: (2016)

Whole exome sequencing of duodenal neuroendocrine tumors in patients with neurofibromatosis type 1
por: Noë, Michaël, et al.
Publicado: (2018)

Gene Expression Profiling of Pancreas Neuroendocrine Tumors with Different Ki67-Based Grades
por: Simbolo, Michele, et al.
Publicado: (2021)

DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association
por: Lakis, Vanessa, et al.
Publicado: (2021)

Harnessing the epigenome to boost immunotherapy response in non-small cell lung cancer patients
por: Gkountakos, Anastasios, et al.
Publicado: (2021)

Characterization and digital spatial deconvolution of the immune microenvironment of intraductal oncocytic papillary neoplasms (IOPN) of the pancreas
por: Pea, Antonio, et al.
Publicado: (2023)

Pancreatic cancer arising in the remnant pancreas is not always a relapse of the preceding primary
por: Luchini, Claudio, et al.
Publicado: (2018)

Targeted next-generation sequencing of cancer genes dissects the molecular profiles of intraductal papillary neoplasms of the pancreas
por: Amato, Eliana, et al.
Publicado: (2014)

An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide
por: Bevere, Michele, et al.
Publicado: (2023)

Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring
por: Luchini, Claudio, et al.
Publicado: (2022)

Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol
por: Malleo, Giuseppe, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j6pj92gdttcion9n748sojdo13